Campaigns must balance regulatory compliance with the need to engage consumers directly in a digital-first space
Semaglutide acts solely as a GLP-1 receptor agonist, whereas tirzepatide combines the action of GLP-1 with GIP receptor agonism
This hepatic effect operates through glucagon receptor activation and has implications for anyone studying metabolic syndrome comprehensively

You should not take Contrave if you: Have uncontrolled high blood pressure Have anorexia or bulimia Have or have had seizures Use other medicines that contain bupropion such as Wellbutrin, Wellbutrin SR, Wellbutrin XL, Aplenzin, or Zyban Are undergoing an abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiepileptic drugs Drink a lot of alcohol and abruptly stop drinking Have kidney disease Have liver disease (it may cause liver dysfunction or hepatitis) Are depressed or have suicidal feelings Have current or recent (within the past 7-14 days) use of opioids or opiate drugs You should not take Contrave under these circumstances either: If youre pregnant, breastfeeding, or planning to become pregnant If youve taken an MAOI (monoamine oxidase inhibitor), such as Nardil, Parnate, or Marplan in the past 14 days If youre taking any opioids or opiate drugs If youre dependent on opioids or using methadone or buprenorphine If you are in opioid withdrawal If you take opioids or opiates right after stopping Contrave, you may be more sensitive to them and require lower doseswhich poses a risk of overdose

Developments that may shape compounded semaglutide programs going forward include: Advanced compounding techniques: Innovations in compounding technology can allow for more precise customization of formulations for patients with documented specific needs
Always consult your healthcare provider before starting or stopping any medication or supplement program